Aug 6, 2026 11:02AM
Aug 6, 2026 11:01AM
May 7, 2026 02:38PM
Feb 21, 2026 04:00PM
Feb 17, 2026 11:01AM
Dec 12, 2025 01:36AM
Dec 3, 2025 03:04PM Genmab closes $2.5 billion debt offering to fund Merus acquisition
Dec 3, 2025 03:03PM
Nov 18, 2025 04:02PM
Nov 18, 2025 04:01PM
Nov 10, 2025 07:13AM
Nov 10, 2025 07:12AM
Nov 6, 2025 11:02AM
Oct 21, 2025 08:13AM Genmab launches $97 per share tender offer for Merus
Oct 13, 2025 04:48AM
Oct 6, 2025 08:44AM
Oct 3, 2025 07:53AM
Oct 3, 2025 06:41AM
Sep 30, 2025 04:26AM
Sep 29, 2025 01:09PM
Sep 29, 2025 01:08AM Genmab agrees to acquire Merus for $8 billion in all-cash deal
Sep 29, 2025 01:08AM
Feb 12, 2025 11:01AM
Nov 6, 2024 11:01AM
Aug 9, 2024 08:04AM
Aug 8, 2024 11:03AM
Aug 8, 2024 11:01AM
Aug 8, 2024 11:00AM Genmab Updates 2024 Financial Guidance
Aug 8, 2024 11:00AM
May 21, 2024 11:07AM
May 21, 2024 11:06AM
May 2, 2024 11:01AM
Apr 3, 2024 05:41AM
Apr 3, 2024 01:34AM
Feb 14, 2024 11:02AM Genmab Publishes 2023 Annual Report
Apr 14, 2022 05:37AM
Apr 13, 2022 06:53PM
Apr 13, 2022 05:26PM
Apr 13, 2022 05:26PM
Apr 13, 2022 05:25PM
Apr 13, 2022 05:25PM
Sep 9, 2021 07:00AM Clinical Trial of Investigational Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory B-cell non-Hodgkin’s Lymphoma (B-NHL) Published in The Lancet
Apr 13, 2021 09:26AM
Jun 10, 2020 06:04AM
Jun 10, 2020 06:00AM
Jun 10, 2020 06:00AM
Jun 10, 2020 06:00AM
Jul 18, 2019 05:59AM
Jul 17, 2019 08:30PM Genmab Prices its Initial Public Offering of American Depositary Shares (ADSs) in the United States

1,177,108 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All